Bottom line
Is FMADX a good fund? The bottom line
FMADX is an actively managed alternatives mutual fund from Fidelity.
Its expense ratio is 1.1% — about $110 a year on every $10,000 invested, cheaper than 72% of alternatives funds we track.
With $637 million in net assets and 35 holdings, its largest position is Mastercard Inc (15.0%) and the top 10 make up 76% of the portfolio.
What to watch
- Concentrated: top 10 holdings are 76% of assets
- High turnover (11% a year) can mean more taxable distributions
Updated Nov 19, 2026
What FMADX invests in
Fidelity SAI Merger Arbitrage Fund seeks capital appreciation.
"Employing a merger arbitrage strategy that seeks to generate returns from discrepancies in asset pricing before and after merger or reorganization events. Executing the fund's merger arbitrage strategy through investments in equity securities and equity related derivative instruments, including special purpose acquisition vehicles (""SPACs""), of companies that are or may be involved in publicly announced or reported merger or re-organization events (including pre-definitive and definitive takeovers, buyouts, liquidations, corporate simplifications, spin offs, and other similar corporate transactions and reorganizations), including stock-for-stock, cash, and mixed consideration mergers and acquisitions (""a Merger Transaction""), or companies that the Adviser believes may be involved in Merger Transactions. Utilizing other types of securities such as debt securities (including unrated…
From the fund's prospectus (filed Mar 27, 2026).
What FMADX costs
On a $10,000 investment, FMADX's 1.1% expense ratio costs about $110 a year. The prospectus estimates $1,422 in total costs over 10 years (assuming 5% annual returns). The median alternatives fund charges 1.54%.
FMADX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Mastercard Inc | 15.02% |
| 2 | Warner Bros Discovery Inc | 9.39% |
| 3 | Kenvue Inc | 8.99% |
| 4 | Ust Bills | 8.28% |
| 5 | Electronic Arts Inc | 8.24% |
| 6 | Nvidia Corp | 7.88% |
| 7 | Apogee Therapeutics Inc | 4.99% |
| 8 | Digitalbridge Group Inc | 4.70% |
| 9 | Crinetics Pharmaceuticals Inc | 4.26% |
| 10 | Bio Techne Corp | 4.25% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 76% of the fund. See all top 25 holdings and asset mix →